Caboxen is identified as a cabozantinib product available in 20 mg and 80 mg strengths. Cabozantinib is an oral targeted anticancer medicine classified as a tyrosine kinase inhibitor (TKI).
It works by blocking several proteins involved in cancer-cell growth, survival, and blood-vessel formation. Although this mechanism can help control certain cancers, it can also affect normal body functions and cause unwanted side effects.
The severity and frequency of adverse reactions may vary depending on the patient’s condition, prescribed dose, treatment duration, formulation, and other medicines being used.
Patients should understand the possible side effects before starting treatment and report concerning symptoms to their healthcare professional.
Important: The exact dosage form of Caboxen has not been independently confirmed. The side-effect information below describes known risks associated with cabozantinib and should be interpreted alongside the official prescribing information for the actual formulation.
1. Common Side Effects of Cabozantinib
Some adverse reactions occur relatively frequently during cabozantinib treatment.
Commonly reported side effects include:
- Diarrhea.
- Fatigue and weakness.
- Nausea.
- Vomiting.
- Decreased appetite.
- Weight loss.
- High blood pressure.
- Hand-foot skin reaction.
- Mouth sores.
- Constipation.
- Abdominal discomfort.
- Changes in taste.
- Hair color changes.
- Voice changes.
- Headache.
- Swelling in the hands or feet.
Not every patient experiences these reactions. Some symptoms may improve with appropriate medical management, while others may require dose modification.
2. Diarrhea
Diarrhea is one of the commonly reported adverse reactions associated with cabozantinib.
It may range from mild loose stools to frequent and severe bowel movements.
Possible Symptoms
- Frequent bowel movements.
- Loose or watery stools.
- Abdominal cramping.
- Urgent bowel movements.
- Increased thirst.
- Weakness.
- Signs of dehydration.
Management Considerations
Patients should:
- Inform their healthcare professional if diarrhea develops.
- Maintain appropriate fluid intake according to medical advice.
- Follow the prescribed dietary recommendations.
- Avoid taking additional medicines without professional guidance.
- Seek medical attention if diarrhea becomes severe or persistent.
Severe diarrhea may cause dehydration and electrolyte disturbances and may require treatment interruption or dose modification.
3. Fatigue and Weakness
Fatigue is another commonly reported side effect.
Patients may experience tiredness that affects everyday activities, physical activity, or concentration.
Possible Symptoms
- Persistent tiredness.
- Reduced energy.
- General weakness.
- Difficulty concentrating.
- Reduced physical endurance.
- Increased need for rest.
Management Considerations
Patients may benefit from:
- Maintaining a balanced daily routine.
- Getting adequate rest.
- Eating nutritious meals.
- Maintaining appropriate hydration.
- Discussing persistent fatigue with their healthcare professional.
Severe or sudden weakness should be medically evaluated because it may indicate another complication.
4. Nausea and Vomiting
Cabozantinib may cause nausea and vomiting in some patients.
These symptoms can affect appetite, hydration, and nutritional intake.
Possible Symptoms
- Feeling sick.
- Vomiting.
- Reduced appetite.
- Abdominal discomfort.
- Difficulty maintaining normal food intake.
Patients should inform their healthcare professional if symptoms persist or interfere with eating and drinking.
Appropriate supportive medicines may be prescribed when necessary.
5. Decreased Appetite and Weight Loss
Some patients experience reduced appetite during cabozantinib treatment.
This may lead to inadequate food intake and unintended weight loss.
Possible Symptoms
- Reduced hunger.
- Feeling full quickly.
- Changes in taste.
- Reduced interest in food.
- Unintentional weight loss.
- General weakness.
Patients should monitor significant changes in body weight and discuss nutritional difficulties with their healthcare professional.
6. High Blood Pressure
Cabozantinib can increase blood pressure or worsen existing hypertension.
High blood pressure may develop without obvious symptoms, making regular monitoring important.
Possible Symptoms
- Headache.
- Dizziness.
- Blurred vision.
- Chest discomfort.
- Shortness of breath.
Some patients may not experience any noticeable symptoms.
Blood pressure should be checked before treatment and regularly during therapy.
Severe or uncontrolled hypertension may require additional medication, treatment interruption, or dose adjustment.
7. Hand-Foot Skin Reaction
Hand-foot skin reaction, also known as palmar-plantar erythrodysesthesia, is an important adverse reaction associated with cabozantinib.
It affects the palms of the hands and soles of the feet.
Possible Symptoms
- Redness.
- Swelling.
- Pain.
- Burning sensations.
- Skin tenderness.
- Blisters.
- Peeling skin.
- Difficulty walking or using the hands.
Patients should report early skin changes to their healthcare professional.
Severe reactions may interfere with daily activities and require treatment modification.
8. Mouth Sores and Oral Discomfort
Cabozantinib may cause inflammation or irritation inside the mouth.
Possible Symptoms
- Mouth ulcers.
- Painful sores.
- Redness.
- Dry mouth.
- Discomfort while eating.
- Difficulty swallowing certain foods.
Maintaining oral hygiene and reporting persistent symptoms may help prevent complications.
Patients should consult their healthcare professional before using mouth treatments or other products to manage oral symptoms.
9. Constipation and Abdominal Discomfort
Some patients may experience constipation or abdominal discomfort during treatment.
Possible Symptoms
- Infrequent bowel movements.
- Hard stools.
- Bloating.
- Abdominal cramps.
- Difficulty passing stools.
Persistent or worsening abdominal pain should not be ignored.
Severe abdominal pain may indicate a serious gastrointestinal complication, including perforation.
10. Hair and Voice Changes
Cabozantinib may cause changes in hair color or texture.
Some patients may also experience changes in their voice, including hoarseness.
These effects may vary between individuals.
Patients should report persistent or worsening voice changes, especially when accompanied by difficulty breathing or swallowing.
11. Serious Side Effects of Cabozantinib
In addition to common adverse reactions, cabozantinib can cause serious complications that require immediate medical attention.
Important serious adverse reactions include:
| Serious adverse reaction | Possible warning signs |
|---|---|
| Severe bleeding | Vomiting blood, black stools, uncontrolled bleeding |
| Gastrointestinal perforation | Severe abdominal pain, abdominal tenderness |
| Fistula formation | Unusual passage between organs or body structures |
| Blood clots | Chest pain, breathing difficulty, leg swelling |
| Stroke or heart attack | Sudden weakness, speech difficulty, chest pain |
| Severe hypertension | Severe headache, visual disturbances |
| Liver toxicity | Jaundice, dark urine, abdominal discomfort |
| Proteinuria | Abnormal urine protein, swelling |
| Osteonecrosis of the jaw | Persistent jaw pain, exposed bone |
| RPLS/PRES | Seizures, confusion, severe headache, visual changes |
| Impaired wound healing | Delayed healing after surgery or injury |
These complications may be uncommon, but they can be medically serious.
12. Risk of Severe Bleeding
Cabozantinib can cause serious or potentially fatal bleeding.
Patients should be especially careful if they have a history of bleeding disorders or significant gastrointestinal bleeding.
Warning Signs
- Vomiting blood.
- Black or tarry stools.
- Coughing up blood.
- Blood in the urine.
- Unusual bruising.
- Persistent nosebleeds.
- Uncontrolled bleeding.
Seek urgent medical attention if significant bleeding occurs.
13. Gastrointestinal Perforation and Fistula
Gastrointestinal perforation and fistula formation are serious complications associated with cabozantinib.
A perforation occurs when a hole develops in the gastrointestinal tract. A fistula is an abnormal connection between two organs or body structures.
Possible Warning Signs
- Severe abdominal pain.
- Persistent abdominal tenderness.
- Fever with abdominal symptoms.
- Unusual passage of fluid or material.
- Severe gastrointestinal discomfort.
Patients experiencing these symptoms require urgent medical evaluation.
14. Blood Clots and Cardiovascular Complications
Cabozantinib may increase the risk of arterial and venous thromboembolic events.
Potential complications include:
- Deep vein thrombosis.
- Pulmonary embolism.
- Heart attack.
- Stroke.
Warning Signs
- Sudden chest pain.
- Sudden shortness of breath.
- Pain or swelling in one leg.
- Sudden weakness on one side of the body.
- Difficulty speaking.
- Sudden vision changes.
These symptoms require immediate medical attention.
15. Liver-Related Side Effects
Cabozantinib may cause liver-related abnormalities.
Healthcare professionals may monitor liver enzymes and other relevant laboratory parameters during treatment.
Possible Symptoms
- Yellowing of the skin or eyes.
- Dark urine.
- Persistent nausea.
- Unusual tiredness.
- Upper-right abdominal discomfort.
- Loss of appetite.
Liver-related abnormalities may occur even before noticeable symptoms develop, making laboratory monitoring important.
16. Kidney-Related Side Effects
Proteinuria is a recognized adverse reaction associated with cabozantinib.
It refers to an increased amount of protein in the urine.
Patients may not experience noticeable symptoms, so urine testing may be necessary.
Possible signs include:
- Swelling in the legs.
- Swelling around the eyes.
- Foamy urine.
- Changes in urine output.
- Sudden weight gain caused by fluid retention.
Severe proteinuria may require treatment interruption or discontinuation.
17. Osteonecrosis of the Jaw
Osteonecrosis of the jaw is a serious condition involving damage to jawbone tissue.
Possible symptoms include:
- Persistent jaw pain.
- Swelling.
- Gum infections.
- Exposed jawbone.
- Difficulty chewing.
- Delayed healing after dental procedures.
Patients should inform their oncologist about dental problems and planned invasive dental procedures.
18. Side Effects Requiring Emergency Attention
Medical emergency symptoms
Patients should seek immediate medical attention if they experience:
- Severe or uncontrolled bleeding.
- Severe abdominal pain.
- Sudden chest pain.
- Difficulty breathing.
- Sudden weakness or speech difficulties.
- Seizures.
- Severe headache with confusion or vision changes.
- Symptoms suggesting a serious blood clot.
Do not wait for the next scheduled appointment when serious symptoms occur.
19. Factors That May Influence Side Effects
The risk and severity of cabozantinib adverse reactions may depend on several factors.
These include:
Prescribed dose: Higher exposure may increase the risk of certain adverse reactions.
Treatment duration: Some complications may develop after prolonged treatment.
Individual health: Existing medical conditions may influence treatment tolerance.
Liver function: Impaired liver function can affect medicine exposure.
Other medicines: Drug interactions may increase or decrease cabozantinib exposure.
Treatment combinations: Using cabozantinib with another anticancer medicine may change the overall safety profile.
The treating oncologist evaluates these factors when planning and monitoring treatment.
20. How to Manage Side Effects During Treatment
Patients should not attempt to manage serious adverse reactions without professional guidance.
General precautions include:
- Report new or worsening symptoms promptly.
- Attend scheduled medical appointments.
- Follow recommended blood and urine testing.
- Monitor blood pressure as instructed.
- Maintain appropriate hydration.
- Follow the recommended nutritional plan.
- Maintain oral hygiene.
- Report skin reactions early.
- Inform healthcare professionals about all other medicines.
- Never change the prescribed dose independently.
Depending on the severity of an adverse reaction, the oncologist may recommend supportive treatment, temporary interruption, dose reduction, or discontinuation.
21. Frequently Asked Questions About Caboxen Side Effects
1. What are the most common side effects of Caboxen?
Commonly reported cabozantinib side effects include diarrhea, fatigue, nausea, vomiting, reduced appetite, weight loss, hypertension, and hand-foot skin reactions.
2. Can Caboxen cause hair loss?
Changes in hair color or texture have been reported with cabozantinib. Hair-related effects can vary between patients.
3. Does cabozantinib cause high blood pressure?
Yes. Cabozantinib may increase blood pressure or worsen existing hypertension. Regular monitoring is important.
4. Can Caboxen cause diarrhea?
Yes. Diarrhea is a commonly reported adverse reaction. Severe or persistent diarrhea should be reported promptly.
5. Can cabozantinib cause fatigue?
Yes. Fatigue and weakness may occur during treatment and can affect daily activities.
6. Can Caboxen affect the liver?
Yes. Liver-related abnormalities have been reported. Healthcare professionals may monitor liver function during treatment.
7. Can cabozantinib cause mouth ulcers?
Yes. Mouth sores and oral discomfort may occur in some patients.
8. Are the side effects of cabozantinib always serious?
No. Some adverse reactions are mild or manageable, while others can be serious or life-threatening. Individual assessment is essential.
9. Should I stop Caboxen if I experience side effects?
Do not independently stop or change treatment. Contact your prescribing oncologist for advice. Emergency symptoms require immediate medical attention.
10. Why is regular monitoring necessary?
Monitoring helps healthcare professionals identify adverse reactions early, assess treatment tolerance, and determine whether treatment adjustments are needed.
Important Side Effect Disclaimer
The side-effect information on this page is intended for educational purposes. It does not include every possible adverse reaction and should not replace the official prescribing information for the specific cabozantinib formulation.
The exact safety profile of Caboxen must be assessed using verified product documentation.